United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,288 | -29,861 | -20,050 | -9,403 | -75,600 |
| Depreciation Amortization | 3,515 | 2,157 | 1,275 | 519 | 910 |
| Accounts receivable | -2,969 | -2,026 | -802 | -479 | -398 |
| Accounts payable and accrued liabilities | 1,826 | -981 | 34 | 1,004 | 2,530 |
| Other Working Capital | -6,195 | -5,169 | -1,556 | -463 | 1,740 |
| Other Operating Activity | 2,212 | 4,358 | 1,549 | 228 | 39,708 |
| Operating Cash Flow | $-38,899 | $-31,522 | $-19,550 | $-8,594 | $-31,110 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -152,520 | N/A | -37,170 | N/A | -56,659 |
| PPE Investments | -647 | -411 | -305 | -168 | -640 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 19,790 |
| Purchase Of Investment | N/A | -102,444 | N/A | -22,323 | -1,000 |
| Sale Of Investment | 18,386 | 22,779 | 21,876 | 14,564 | 76,453 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -30,794 |
| Investing Cash Flow | $-134,781 | $-80,076 | $-15,599 | $-7,927 | $7,150 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -69 | N/A | N/A | N/A | -42 |
| Common Stock Issued | 6 | 6 | 4 | 4 | 210,585 |
| Common Stock Repurchased | -2,802 | -2,802 | -2,459 | -995 | -4,072 |
| Other Financing Activity | -17 | -62 | -40 | -19 | 139 |
| Financing Cash Flow | $-2,882 | $-2,858 | $-2,495 | $-1,010 | $206,610 |
| Beginning Cash Position | 200,935 | 200,935 | 200,935 | 200,935 | 18,280 |
| End Cash Position | 24,373 | 86,479 | 163,291 | 183,404 | 200,930 |
| Net Cash Flow | $-176,562 | $-114,456 | $-37,644 | $-17,531 | $182,650 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,899 | -31,522 | -19,550 | -8,594 | -31,110 |
| Capital Expenditure | -687 | -436 | -330 | -193 | -640 |
| Free Cash Flow | -39,586 | -31,958 | -19,880 | -8,787 | -31,750 |